Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation

- Gingras, Marie-Claude, Covington, Kyle R., Fisher, William E., Pilarsky, Christian, Grützmann, Robert, Overman, Michael J., Jamieson, Nigel B., Van Buren II, George, Drummond, Jennifer, Walker, Kimberly, Hampton, Oliver A., Australian Pancreatic Cancer Genome Initiative,, Chang, David K., Wong, Rachel, Donehower, Lawrence A., Gill, Anthony J., Ittmann, Michael M., Creighton, Chad J., Johns, Aamber L., Shinbrot, Eve, Dewal, Ninad

Clinical and pathologic features of familial pancreatic cancer

- Humphris, Jeremy L., Johns, Amber L., Mead, R. Scott, Gill, Anthony J., Samra, Jaswinder S., Kench, James G., Musgrove, Elizabeth A., Tucker, Katherine M., Spigelman, Allan D., Waddell, Nic, Grimmond, Sean M., Biankin, Andrew V. Biankin, Simpson, Skye H., Australian Pancreatic Cancer Genome Initiative,, Cowley, Mark J., Pajic, Marina, Chang, David K., Nagrial, Adnan M., Chin, Venessa T., Chantrill, Lorraine A., Pinese, Mark

Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer

- Moran-Jones, Kim, Gloss, Brian S., Spong, Suzanne M., Scarlett, Christopher J., Hacker, Neville F., Ghosh, Sue, Mok, Samuel C., Birrer, Michael J., Samimi, Goli, Murali, Rajmohan, Chang, David K., Colvin, Emily K., Jones, Marc D., Yuen, Samuel, Howell, Viive M., Brown, Laura M., Wong, Carol W.

Genomic analyses identify molecular subtypes of pancreatic cancer

- Bailey, Peter, Chang, David K., Nourse, Craig, Nones, Katia, Johns, Amber L., Patch, Ann-Marie, Murtaugh, L. Charles, Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourbakhsh, Ehsan, Wani, Shivangi, Fink, Lynn, Holmes, Oliver, Chin, Venessa, Scarlett, Christopher J., Gingras, Marie-Claude, Miller, David K., Christ, Angelika N., Bruxner, Tim J. C., Quinn, Michael C.

Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater

- Chang, David K., Jamieson, Nigel B., Nagrial, Adnan M., Chantrill, Lorraine A., Chin, Venessa T., Pinho, Andreia V., Rooman, Ilse, Cowley, Mark J., Wu, Jianmin, Mead, R. Scott, Colvin, Emily K., Samra, Jaswinder S., Johns, Amber L., Corbo, Vincenzo, Bassi, Claudio, Falconi, Massimo, Lawlor, Rita T., Crippa, Stefano, Sperandio, Nicola, Bersani, Samantha, Dickson, Euan J., Mohamed, Mohamed A. A., Oien, Karin A., Scarlett, Christopher J., Foulis, Alan K., Musgrove, Elizabeth A., Sutherland, Robert L., Kench, James G., Carter, C. Ross, Gill, Anthony J., Scarpa, Aldo, McKay, Colin J., Biankin, Andrew V., Pajic, Marina, Chou, Angela, Pinese, Mark, Humphris, Jeremy L., Jones, Marc D., Toon, Christopher

Hypermutation in pancreatic cancer

- Humphris, Jeremy L., Patch, Ann-Marie, Quinn, Michael C. J., Bruxner, Timothy J. C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Stone, Andrew, Wilson, Peter J., Nones, Katia, Scarlett, Christopher J., Bailey, Peter J., Johns, Amber L., McKay, Skye, Chang, David K., Miller, David K., Pajic, Marina, Kassahn, Karin S.

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

- Biankin, Andrew V., Waddell, Nicola, Kassahn, Karin S., Gingras, Marie-Claude, Muthuswamy, Lakshmi B., Johns, Amber L., Miller, David K., Wilson, Peter J., Patch, Ann-Marie, Wu, Jianmin, Chang, David K., Cowley, Mark J., Gardiner, Brooke B., Song, Sarah, Harliwong, Ivon, Idrisoglu, Senel, Nourse, Craig, Nourbakhsh, Ehsan, Manning, Suzanne, Wani, Shivangi, Scarlett, Christopher J.

Retinoid signaling in pancreatic cancer, injury and regeneration

- Colvin, Emily K., Susanto, Johana M., Musgrove, Elizabeth A., Sutherland, Robert L., Apte, Minoti V., Scarlett, Christopher J., Biankin, Andrew V., Kench, James G., Ong, Vivienna N., Mawson, Amanda, Pinese, Mark, Chang, David K., Rooman, Ilse, O'Toole, Sandra A., Segara, Davendra

Sex differences in oncogenic mutational processes

- Li, Constance H., Bailey, MH, Bailey, PJ, Balasundaram, M, Balu, S, Bandopadhayay, P, Prokopec, Stephenie D., Campbell, Peter J., Scarlett, Christopher J., Chang, David K., Cooke, Sussanah L., Deshpande, Vikram, Faltas, Bishoy M., Faquin, William C., Garraway, Levi, Getz, Gad, Grimmond, Sean M., Haider, Syed, Sun, Ren X., Hoadley, KA, Jiao, W, Kaiser, VB, Karlic, R, Kato, M, Kübler, K, Lazar, AJ, Li, CH, Louis, DN, Margolin, A, Yousif, Fouad, Martin, S, Nahal-Bose, HK, Nielsen, GP, Nik-Zainal, S, Omberg, L, P¿ng, C, Perry, MD, Polak, P, Rheinbay, E, Rubin, MA, Schmitz, Nathaniel, Semple, CA, Sgroi, DC, Shibata, T, Siebert, R, Smith, J, Stein, LD, Stobbe, MD, Sun, RX, Thai, K, Wright, DW, Al-Shahrour, Fatima, Wu, CL, Yuan, K, Zhang, J, Boutros, PC, Aaltonen, LA, Abascal, F, Abeshouse, A, Aburatani, H, Adams, DJ, Agrawal, N, Atwal, Gurnit, Ahn, KS, Ahn, SM, Aikata, H, Akbani, R, Akdemir, KC, Al-Ahmadie, H, Al-Sedairy, ST, Al-Shahrour, F, Alawi, M, Albert, M, Bailey, Peter J., Aldape, K, Alexandrov, LB, Ally, A, Alsop, K, Alvarez, EG, Amary, F, Amin, SB, Aminou, B, Ammerpohl, O, Anderson, MJ, Biankin, Andrew V., Ang, Y, Antonello, D, Anur, P, Aparicio, S, Appelbaum, EL, Arai, Y, Aretz, A, Arihiro, K, Ariizumi, SI, Armenia, J, Boutros, Paul C., Arnould, L, Asa, S, Assenov, Y, Atwal, G, Aukema, S, Auman, JT, Aure, MR, Awadalla, P, Aymerich, M, Bader, GD

Targeting mTOR dependency in pancreatic cancer

- Morran, Douglas C., Wu, Jianmin, Australian Pancreatic Cancer Genome Initiative,, Oien, Karin A., McKay, Colin J., Carter, C. Ross, Gillen, Gerry, Champion, Sue, Pimlott, Sally L., Anderson, Kurt I., Evans, T. R. Jeffry, Grimmon , Sean M., Jamieson, Nigel B., Biankin, Andrew V., Samson, Owen J., Morton, Jennifer P., Mrowinska, Agata, Kalna, Gabriela, Karim, Saadia A., Au, Amy Y. M., Scarlett, Christopher J., Chang, David K., Pajak, Malgorzata Z.

The epigenetic agents suberoylanilide hydroxamic acid and 5-AZA-2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo

- Susanto, Johana M., Colvin, Emily K., Biankin, Andrew V., Scarlett, Christopher J., Pinese, Mark, Chang, David K., Pajic, Marina, Mawson, Amanda, Caldon, C. Elizabeth, Musgrove, Elizabeth A., Henshall, Susan M., Sutherland, Robert L.

Whole genomes redefine the mutational landscape of pancreatic cancer

- Waddell, Nicola, Pajic, Marina, Quinn, Michael C. J., Robertson, Alan J., Fadlullah, Muhammad Z. H., Bruxner, Tim J. C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Patch, Ann-Marie, Scarlett, Christopher J., Chang, David K., Kassahn, Karin S., Bailey, Peter, Johns, Amber L., Miller, David, Nones, Katia, Quek, Kelly

Whole-genome landscape of pancreatic neuroendocrine tumours

- Scarpa, Aldo, Chang, David K., Rusev, Borislav, Scardoni, Maria, Antonello, Davide, Barbi, Stefano, Sikora, Katarzyna O., Cingarlini, Sara, Vicentini, Caterina, McKay, Skye, Quinn, Michael C. J., Bruxner, Timothy J. C., Nones, Katia, Scarlett, Christopher J., Corbo, Vincenzo, Patch, Ann-Marie, Bailey, Peter, Lawlor, Rita T., Johns, Amber L., Miller, David K., Mafficini, Andrea